Tg Therapeutics, Inc.

MetLife Investment Management, LLC TGTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

80,434

Value ($000)

2,398

Weight

0.0%

2018 Q3 - 2025 Q4 (30 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	2,398	0.0%	80,434	12/31/2025
2025 Q3	11/13/2025	3,064	0.0%	84,805	9/30/2025
2025 Q2	8/13/2025	3,114	0.0%	86,535	6/30/2025
2025 Q1	5/14/2025	3,203	0.0%	81,232	3/31/2025
2024 Q4	2/13/2025	2,539	0.0%	84,360	12/31/2024
2024 Q3	11/13/2024	1,885	0.0%	80,608	9/30/2024
2024 Q2	8/13/2024	1,434	0.0%	80,608	6/30/2024
2024 Q1	5/14/2024	1,100	0.0%	72,322	3/31/2024
2023 Q4	4/22/2024	1,235	0.0%	72,322	12/31/2023
2023 Q3	5/9/2024	605	0.0%	72,322	9/30/2023
2023 Q2	4/29/2024	1,796	0.0%	72,322	6/30/2023
2023 Q1	5/9/2024	1,054	0.0%	70,096	3/31/2023
2022 Q4	5/10/2024	829	0.0%	70,096	12/31/2022
2022 Q3	5/10/2024	415	0.0%	70,096	9/30/2022
2022 Q2	5/10/2024	272	0.0%	64,003	6/30/2022
2022 Q1	5/10/2024	678	0.0%	71,269	3/31/2022
2021 Q4	5/17/2024	852	0.0%	44,826	12/31/2021
2021 Q3	5/17/2024	1,492	0.0%	44,826	9/30/2021
2021 Q2	5/17/2024	1,739	0.0%	44,826	6/30/2021
2021 Q1	5/17/2024	2,161	0.0%	44,826	3/31/2021
2020 Q4	5/24/2024	2,438	0.0%	46,863	12/31/2020
2020 Q3	5/24/2024	1,254	0.0%	46,863	9/30/2020
2020 Q2	5/24/2024	839	0.0%	43,050	6/30/2020
2020 Q1	7/12/2023	371	0.0%	37,719	3/31/2020
2019 Q4	7/12/2023	419	0.0%	37,719	12/31/2019
2019 Q3	7/12/2023	212	0.0%	37,719	9/30/2019
2019 Q2	7/12/2023	326	0.0%	37,719	6/30/2019
2019 Q1	7/13/2023	227	0.0%	28,284	3/31/2019
2018 Q4	7/13/2023	116	0.0%	28,284	12/31/2018
2018 Q3	7/13/2023	158	0.0%	28,284	9/30/2018